Lacquer crack formation after photodynamic therapy

European Journal of Ophthalmology

Volumn 13, Issue 8, 2003, Pages 729-733

  Ladas, Ioannis D ^a,c   Moschos, M M ^b   Rouvas, A A ^a   Karagiannis, D A ^a   Kokolakis, S N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c NONE   (Greece)

Author keywords

Choroidal neovascularization; Lacquer crack; Myopia; Photodynamic therapy; Verteporfin

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MYOPIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINA INJURY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME;

EID: 0242680137     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210301300813     Document Type: Article

References (7)

1. Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP report 1. Ophthalmology 2001; 108: 841-52.
2. Pruett RC, Weiter JJ, Goldstein RB. Myopic cracks, angioid streaks, and traumatic tears in Bruch's membrane. Am J Ophthalmol 1987; 103: 537-43.
3. Soubrane G, Pison J, Bornert P, et al. Néo-vaisseaux sousrétiniens de la myopie dégénérative: résultats de la photocoagulation. Bull Soc Ophtalmol Fr 1986; 86: 269-72.
4. Secretan M, Kuhn D, Soubrane G, Coscas G. Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol 1997; 7: 307-16.
5. Brancato R, Pece A, Avanza P, Radrizzani E. Photocoagulation scar expansion after laser therapy of choroidal neovascularization in degenerative myopia. Retina 1990; 10: 239-43.
6. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of a randomized clinical trial-TAP report 1. Arch Ophthalmol 1999; 117: 1329-45.
7. Verteporfin in Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001; 131: 541-60.